BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 33359741)

  • 21. [Clinical analysis of 76 cases of sentinel lymph node detection in cervical cancer and endometrial cancer].
    Liang SC; Wang ZQ; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2017 Sep; 52(9):605-611. PubMed ID: 28954449
    [No Abstract]   [Full Text] [Related]  

  • 22. Similar distribution of pelvic sentinel lymph nodes and nodal metastases in cervical and endometrial cancer. A prospective study based on lymphatic anatomy.
    Lührs O; Bollino M; Ekdahl L; Lönnerfors C; Geppert B; Persson J
    Gynecol Oncol; 2022 Jun; 165(3):466-471. PubMed ID: 35437170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High-Risk Subtypes?
    Ye L; Li S; Lu W; He Q; Li Y; Li B; Wang X; Yan Q; Wan X
    Oncologist; 2019 Dec; 24(12):e1381-e1387. PubMed ID: 31270269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sentinel lymph node mapping with indocyanine green in cervical cancer patients undergoing open radical hysterectomy: a single-institution series.
    Bizzarri N; Luigi PA; Ferrandina G; Zannoni GF; Carbone MV; Fedele C; Teodorico E; Gallotta V; Gueli Alletti S; Chiantera V; Fagotti A; Scambia G; Fanfani F
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):649-659. PubMed ID: 33000339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential risks in sentinel lymph node biopsy for cervical cancer: a single-institution pilot study.
    Tu H; Wan T; Zhang X; Gu H; Feng Y; Huang H; Liu J
    World J Surg Oncol; 2020 Jun; 18(1):133. PubMed ID: 32552905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of methylene blue dye for sentinel lymph node mapping in early-stage gynecological cancers - An option for low resource settings.
    Singh N; Agrawal S
    J Cancer Res Ther; 2022; 18(4):1088-1092. PubMed ID: 36149165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers.
    Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F
    Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between sentinel lymph node biopsy and micrometastasis in endometrial cancer.
    Matsuo K; Klar M; Khetan VU; Violette CJ; Youssefzadeh AC; Yessaian AA; Roman LD
    Eur J Obstet Gynecol Reprod Biol; 2022 Aug; 275():91-96. PubMed ID: 35763967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indications and techniques for robotic pelvic and para-aortic lymphadenectomy with sentinel lymph node mapping in gynecologic oncology.
    Wisner KPA; Ahmad S; Holloway RW
    Best Pract Res Clin Obstet Gynaecol; 2017 Nov; 45():83-93. PubMed ID: 28533155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel lymph node sampling in gynaecological cancers: techniques and clinical applications.
    El-Ghobashy AE; Saidi SA
    Eur J Surg Oncol; 2009 Jul; 35(7):675-85. PubMed ID: 18980825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
    Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
    Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity?
    Kim YN; Lee D; Cha J; Kang WJ; Lee YJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
    Gynecol Oncol; 2022 Sep; 166(3):438-443. PubMed ID: 35907682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
    El-Agwany AS; Meleis MH
    Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO).
    Ballester M; Dubernard G; Lécuru F; Heitz D; Mathevet P; Marret H; Querleu D; Golfier F; Leblanc E; Rouzier R; Daraï E
    Lancet Oncol; 2011 May; 12(5):469-76. PubMed ID: 21489874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison Study of Laparoscopic Sentinel Lymph Node Mapping in Endometrial Carcinoma Using Carbon Nanoparticles and Lymphatic Pathway Verification.
    Zuo J; Wu LY; Cheng M; Bai P; Lei CZ; Li N; Zhang GY; Zhao D; Li B
    J Minim Invasive Gynecol; 2019; 26(6):1125-1132. PubMed ID: 30445188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frozen Section for Detection of Lymph Nodes After Cervical Injection with Indocyanine Green (ICG) for Sentinel Lymph Node Technique in Endometrial Cancer Staging.
    Casarin J; Multinu F; Pasupathy K; Weaver A; McGree M; Tortorella L; Torres D; Kumar A; Langstraat C; Huang Y; Ghezzi F; Mariani A; Glaser G
    Ann Surg Oncol; 2018 Nov; 25(12):3692-3698. PubMed ID: 30116949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
    Salvo G; Ramirez PT; Levenback CF; Munsell MF; Euscher ED; Soliman PT; Frumovitz M
    Gynecol Oncol; 2017 Apr; 145(1):96-101. PubMed ID: 28188015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combining Indocyanine Green and Tc
    Lührs O; Ekdahl L; Lönnerfors C; Geppert B; Persson J
    Gynecol Oncol; 2020 Feb; 156(2):335-340. PubMed ID: 31780237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
    Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
    J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The SENTIREC-endo study - Risks and benefits of a national adoption of sentinel node mapping in low and intermediate risk endometrial cancer.
    Bjørnholt SM; Sponholtz SE; Mogensen O; Bouchelouche K; Parner ET; Neumann G; Jochumsen KM; Hamid BH; Davidsen MB; Bjørn SF; Dahl K; Jensen PT
    Gynecol Oncol; 2023 Apr; 171():121-128. PubMed ID: 36893488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.